Previous close | 18.88 |
Open | 19.10 |
Bid | 19.03 x 100 |
Ask | 19.12 x 300 |
Day's range | 18.96 - 19.48 |
52-week range | 15.81 - 41.06 |
Volume | |
Avg. volume | 1,946,850 |
Market cap | 2.328B |
Beta (5Y monthly) | 0.90 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Besides Wall Street's top -and-bottom-line estimates for Guardant Health (GH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Exact Sciences stock surged Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study.